DNA’s ‘Junk’ Now Seen as Lever Controlling Future Health

Almost a decade after the U.S. human genome project was completed, scientists say they have mapped the underlying regulatory system that switches DNA on and off, potentially spurring a wave of new research into the molecular basis of complex diseases such as Type 1 diabetes.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.